Fidson Healthcare Plc (NGX:FIDSON)

Market Cap	175.20B +365.5%
Revenue (ttm)	119.06B +41.4%
Net Income	9.31B +61.1%
EPS	3.88 +54.1%
Shares Out	2.40B
PE Ratio	18.81
Forward PE	10.72
Dividend	1.00 (1.38%)
Ex-Dividend Date	Jul 14, 2025

Volume	1,140,967
Average Volume	1,295,307
Open	73.00
Previous Close	72.50
Day's Range	73.00 - 73.00
52-Week Range	17.05 - 74.00
Beta	0.81
RSI	70.37
Earnings Date	Mar 27, 2026

About Fidson Healthcare

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is headquartered i...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 674
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: FIDSON

Financial Performance

In 2025, Fidson Healthcare's revenue was 119.06 billion, an increase of 41.42% compared to the previous year's 84.19 billion. Earnings were 9.31 billion, an increase of 61.05%.